Patents - Global Data - Dimensions
Grant
Controlled-release PTH compound
Applicants
- Ascendis Pharma Bone Diseases AS
[NORA names: Ascendis Pharma; Private Research]
Abstract
The present invention relates to a controlled-release parathyroid hormone (PTH) compound in which PTH(1-34) is reversibly conjugated to a branched polyethylene glycol. The invention further relates to a pharmaceutical composition of the compound. The compound or pharmaceutical composition is useful for treatment, control, delay or prevention of a condition that can be treated, controlled, delayed or prevented with PTH.
Patent Family Records (38)
Controlled-release PTH compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2024, US-11918628-B2
Controlled-release PTH compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2024, US-11890326-B2
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES A HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGE KENNETT, (...more)
2024, KR-20240013849-A
Dosage Regimen for Controlled Release PTH Compounds
아센디스 파마 본 디지즈 에이/에스 КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)
2024, KR-102627405-B1
DOSAGE REGIMEN FOR CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS LARS HOLTEN-ANDERSEN, KENNETT SPROGOE, DAVID BRIAN KARPF
2024, JP-2024041859-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2024, HU-E063235-T2
Dosing regimen for a controlled release pth compound
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2024, ES-2959995-T3
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2024, EP-4275677-A3
Dosage regimen for controlled release of PTH compounds
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2024, CN-117838873-A
Dosage regimen for controlled release of PTH compounds
Ascendis Pharma Bone Diseases AS L. Holden-Anderson, SPROGOEE KENNETT, D.B. Kapf
2024, CN-109789189-B
Controlled-Release PTH Compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2023, US-20230381284-A1
Dosage Regimen for a Controlled-Release PTH Compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2023, US-20230321198-A1
Dosage Regimen for a Controlled-Release PTH Compound
Ascendis Pharma Bone Diseases AS SPROGÿE KENNETT, SPROGØE KENNETT, CLEEMANN FELIX, (...more)
2023, US-20230248836-A1
Dosage regimen for a controlled-release PTH compound
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, US-11590207-B2
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2023, SI-3518960-T1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, RS-64440-B1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, PL-3518960-T3
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, LT-3518960-T
Dosing Regimens for Controlled-Release PTH Compounds
Ascendis Pharma Bone Diseases AS LARS HOLTEN-ANDERSEN, KENNETT SPROGOE, DAVID BRIAN KARPF
2023, JP-2023017796-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS
2023, IL-304086-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS
2023, IL-265591-B2
Dosage regimen for a controlled-release pth compound
ASCENDIS PHARMA BONE DISEASES AS
2023, IL-265591-B1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, HR-P20231079-T1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, EP-4275677-A2
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2023, EP-3518960-B1
Dosage schedule for a controlled release PTH compound
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, KARPF DAVID BRIAN, (...more)
2023, DK-3518960-T3
Dosage Regimen for a Controlled-Release PTH Compound
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2020, US-20200023041-A1
CONTROLLED RELEASE PTH CONNECTION DOSING MODE
Асцендис Фарма Боун Дизизис А/С КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)
2020, RU-2019112913-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, ZA-201901811-B
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, SG-11201901576Q-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND.
ASCENDIS PHARMA BONE DISEASES AS KENNETT SPROGØE, LARS HOLTEN-ANDERSEN, DAVID BRIAN KARPF
2019, MX-2019003181-A
Dosage regimen for controlled-release PTH compound
ASCENDIS PHARMA BONE DISEASES A HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, KR-20190062496-A
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, EP-3518960-A1
The dosage of controlled release PTH compound
Arsendis Drug Bone Disease Co Ltd HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2019, CN-109789189-A
dosing regimen for a controlled release pth compound
ASCENDIS PHARMA BONE DISEASES AS DAVID BRIAN KARPF, KENNETT SPROGØE, LARS HOLTEN-ANDERSEN
2019, BR-112019005533-A2
Dosage regimen for a controlled-release PTH compound
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2019, AU-2017336249-A1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGÿE KENNETT, (...more)
2018, WO-2018060310-A1
DOSAGE REGIMEN FOR A CONTROLLED-RELEASE PTH COMPOUND
Ascendis Pharma Bone Diseases AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, SPROGOE KENNETT, (...more)
2018, CA-3037442-A1